LALPATHLAB

HealthcareDiagnostics & ResearchLarge Cap
Dr. Lal PathLabs Limited

Dr. Lal PathLabs Limited operates laboratories for pathological investigations in India and internationally within the Healthcare sector, specifically Diagnostics & Research. The c...

हिन्दी में

डॉ. लाल पैथलैब्स लिमिटेड हेल्थकेयर सेक्टर, विशेष रूप से डायग्नोस्टिक्स एंड रिसर्च में, भारत और अंतरराष्ट्रीय स्तर पर पैथोलॉजिकल जांच के लिए प्रयोगशालाएं संचालित करता है। कंपनी बायो...

₹1,933.6+1.83%1D
Previous trading day close · Data updates after market close
1W: -1.9%
1M: +0.7%
6M: +40.1%
1Y: +22.9%
70/100
AverageResearch Score
Market Cap
₹28.2K Cr
Large Cap
P/E Ratio
59.68
Premium
P/B Ratio
12.87
Premium
ROE
21.3%
Strong
ROCE
25.7%
Excellent
Debt / Equity
0.08
Low debt
Div. Yield
1.1%
Low yield
EV/EBITDA
38.75
Expensive
52W Low: ₹1,272.6Current: ₹1,933.652W High: ₹2,038.6
At 86% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
88/100
Growth
Revenue, EPS, profit growth
86/100
Valuation
PE, PB, EV/EBITDA vs sector
18/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
59.68(Premium)
Forward P/E
44.16(Premium)
P/B Ratio
12.87(Premium)
P/S Ratio
11.18(Expensive)
EV/EBITDA
38.75(Expensive)
Dividend Yield
1.1%
5Y CAGR
-0.3%(Moderate)
Revenue Growth
19.1%(Moderate)
Profitability
ROE
21.3%(Excellent)
ROCE
25.7%(Excellent)
ROA
17.2%(Efficient)
Net Margin
18.7%(High)
EBITDA Margin
30.9%
Financial Health
Debt to Equity
0.08(Low debt)
Current Ratio
3.48(Healthy)
Quick Ratio
3.38(Good)
Interest Coverage
30.35x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
56(Neutral)
RSI Exp (14)
46(Neutral)
MACD
11.915(Bullish)
MACD Signal
16.716
BB Position
48%(Middle)
BB Width
6.42%(Normal)
ADX (14)
41.8(Strong trend)
Williams %R
-57.8(Neutral)
MFI (14)
45(Neutral)
CCI (20)
-49(Neutral)
Stoch %K
42(Neutral)
ATR (14)
64.11(Avg True Range)
OBV (M)
24.3(Positive)
1W OBV Chg
-3.8%(Decreasing)
Rel Volume
0.51x(Normal)
Volatility
29.0%(Moderate)
Max DD 1Y
-35.9%(Moderate)
Alpha (CAPM)
13.26%(Outperforming Nifty)
Return vs Nifty
27.6%(Beating Nifty)
EMA 200
1693.6
EMA 50
1893.3
SMA 200
1606.9
vs SMA 50
0.6%(Above SMA50)
vs SMA 200
20.3%(Above SMA200)
Volume
1.68L
Avg Vol 3M
3.3L
Shareholding Pattern
Promoter
53.2%
High confidence
FII
17.2%
DII / MF
21.4%
Strong MF interest
Share LALPATHLAB
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.